IS PHARMA LTD

Company Registration Number:
03337415 (England and Wales)

Unaudited statutory accounts for the year ended 31 December 2025

Period of accounts

Start date: 1 January 2025

End date: 31 December 2025

IS PHARMA LTD

Contents of the Financial Statements

for the Period Ended 31 December 2025

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

IS PHARMA LTD

Directors' report period ended 31 December 2025

The directors present their report with the financial statements of the company for the period ended 31 December 2025

Principal activities of the company

The principal activity of the Company continued to be that of a holding company.



Directors

The directors shown below have held office during the whole of the period from
1 January 2025 to 31 December 2025

T Xing
G Li


The director shown below has held office during the period of
1 January 2025 to 28 October 2025

J Liu


The director shown below has held office during the period of
1 January 2025 to 30 June 2025

A Edwards


The director shown below has held office during the period of
28 October 2025 to 30 December 2025

R Irvine


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
23 July 2026

And signed on behalf of the board by:
Name: G Li
Status: Director

IS PHARMA LTD

Profit And Loss Account

for the Period Ended 31 December 2025

2025 2024


£

£
Turnover: 907,000 9,000
Gross profit(or loss): 907,000 9,000
Operating profit(or loss): 907,000 9,000
Profit(or loss) before tax: 907,000 9,000
Tax: 1,000
Profit(or loss) for the financial year: 908,000 9,000

IS PHARMA LTD

Balance sheet

As at 31 December 2025

Notes 2025 2024


£

£
Current assets
Debtors: 3 3,237,001 3,237,001
Total current assets: 3,237,001 3,237,001
Creditors: amounts falling due within one year: 4 ( 908,000 )
Net current assets (liabilities): 3,237,001 2,329,001
Total assets less current liabilities: 3,237,001 2,329,001
Total net assets (liabilities): 3,237,001 2,329,001
Capital and reserves
Called up share capital: 1 1
Other reserves: 756,000 756,000
Profit and loss account: 2,481,000 1,573,000
Total Shareholders' funds: 3,237,001 2,329,001

The notes form part of these financial statements

IS PHARMA LTD

Balance sheet statements

For the year ending 31 December 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 23 July 2026
and signed on behalf of the board by:

Name: G Li
Status: Director

The notes form part of these financial statements

IS PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 December 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

    Other accounting policies

    Basis of preparation These financial statements have been prepared in accordance with applicable accounting standards and in accordance with Financial Reporting Standard 101 – ‘The Reduced Disclosure Framework (FRS 101)’. The principal accounting policies adopted in the preparation of these financial statements are set out below. These policies have all been applied consistently throughout the period unless otherwise stated. The financial statements have been prepared on a historical cost basis, as modified by certain assets and liabilities measured at fair value.

IS PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 December 2025

  • 2. Employees

    2025 2024
    Average number of employees during the period 0 0

IS PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 December 2025

3. Debtors

2025 2024
£ £
Trade debtors 0 0
Prepayments and accrued income 0 0
Other debtors 3,237,001 3,237,001
Total 3,237,001 3,237,001

IS PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 December 2025

4. Creditors: amounts falling due within one year note

  2024
  £
Other creditors 908,000
Total   908,000